Slide 1: AGM Presentation May 2022
For personal use only AGM Presentation May 2022 Passion to combine economic success with enriching lives for a sustainable future
Slide 2: Disclaimer
Disclaimer For personal use only This document has been prepared by Holista Colltech Limited and comprises written material/slides for a presentation concerning Holista Colltech Limited and its subsidiaries. The presentation is for information purposes only and does not constitute or form part of an
Slide 3: Encouraging Finish to 2021
Encouraging Finish to 2021 Momentum carrying through into current year For personal use only Holista Colltech is an emerging Australian developer of health Record 2021 Revenue Continued Momentum Strong rebound with growth Sales receipts in 1QFY22 hits and wellness products in the across most divisio
Slide 4: Year of Achievements
Year of Achievements Foundations for a stronger 2022 For personal use only Positive First COVID test commercial for All- Increasing order from Natural orders for GI Launch of Country Nano Silver LiteTM and new Farms/ Disinfectant Successful 80LessTM from products: Starbucks Orders for tests showing
Slide 5: Good Recovery in 2021
Good Recovery in 2021 Revenue & margin growth For personal use only Full Year Performance: V-shaped FY21 revenue goes up 13% to record $8m recovery following COVID impacted FY20 $8.2 51.4% $8.0 51.2% $7.8 51.0% Net loss before tax narrowed to $1.2m from $5.6m (2020) $7.6 50.8% $7.4 50.6% $7.2 50.4%
Slide 6: Sales Growth by Divisions
Sales Growth by Divisions Improvement across most business units For personal use only Division Sales 2021 vs. 2020 $m FY20 Outlook Statement FY21 Results 8.5 What we achieved 8.0 Expected to deliver improved FY21 results Improvement in sales and PBT 7.5 Dietary Supplements recovering with pick- Up
Slide 7: Continuing Growth into 2022
Continuing Growth into 2022 Record sales receipts in 1Q 2022 For personal use only $k Growth in Quarterly Cash Receipts 3,000 1-year ago Latest reported quarter Quarterly sales receipts hit high of $2.4m (+34% pcp 2,500 & 17% QoQ) 2,000 1,500 Increases in 1Q22 sales across all 4 divisions with total
Slide 8: Dietary Supplements
Dietary Supplements Developments & updates For personal use only Largest division contributing 77% of FY21 group revenue The Group markets and sells thirty-seven (37) different propriety supplements and owns leading vitamin Growing faster than market with 1Q22 sales up 31% pcp to brands in Malaysia
Slide 9: Healthy Food Ingredients
Healthy Food Ingredients Developments & updates For personal use only Good growth momentum with 1Q22 sales up 79% to $0.6m Holista developed the clean-label low GI premix called GI LiteTM for healthy breads, noodles and pasta, Increasing orders from key customers like US bread supplier as well as he
Slide 10: Infection Control
Infection Control Developments & updates For personal use only Rebound in sales which more than doubled in 1Q22 vs. pcp to $18k Holista offers a range of natural and alcohol-free sanitising solutions that have been effective against Turnaround driven in part by the launch of all-natural Super Bio vi
Slide 11: Ovine Collagen
Ovine Collagen Developments & updates For personal use only Holista is the only Company 1Q22 sales increased 64% to $122k due to increased orders from cosmetic manufacturer producing Australian-made sheep collagen that is extracted using a patented process. Its product is culturally acceptable, full
Slide 12: Positive Outlook
Positive Outlook Improved 2022 results expected For personal use only Rebound in 2021 results with Growth drivers from new momentum persisting into products and global partnerships current year Expanding margins with cost Performance of Infection Control control and change in sales mix recovering wi
Slide 13: Board of Directors & Advisors
Board of Directors & Advisors Expertise to lead the group forward For personal use only Rajen Manicka Walter Joseph Loren King Jay Stephenson Roscoe Moore Chairman & CEO Non-Executive Director Non-Executive Director Company Secretary Advisor Dr Manicka spent nine Successful track record Worked in co
Slide 14: Thank You
For personal use only To join our mailing list please email: update@holistaco.com Thank You For further information, please contact: Corporate Matters: investor@holistaco.com General Enquiries: enquiries@holistaco.com Investor/Media Relations: Brendon Lau (m: 0409 341 613, e: brendon@vantagepointpar